Cartesian Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAC and other ETFs, options, and stocks.

About RNAC

Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. 

CEO
Carsten Brunn
CEOCarsten Brunn
Employees
75
Employees75
Headquarters
Frederick, Maryland
HeadquartersFrederick, Maryland
Founded
2007
Founded2007
Employees
75
Employees75

RNAC Key Statistics

Market cap
260.99M
Market cap260.99M
Price-Earnings ratio
-1.44
Price-Earnings ratio-1.44
Dividend yield
Dividend yield
Average volume
184.30K
Average volume184.30K
High today
$8.42
High today$8.42
Low today
$7.38
Low today$7.38
Open price
$7.46
Open price$7.46
Volume
278.12K
Volume278.12K
52 Week high
$15.57
52 Week high$15.57
52 Week low
$5.60
52 Week low$5.60

Stock Snapshot

With a market cap of 260.99M, Cartesian Therapeutics(RNAC) trades at $8.34. The stock has a price-to-earnings ratio of -1.44.

As of 2026-05-07, Cartesian Therapeutics(RNAC) stock has fluctuated between $7.38 and $8.42. The current price stands at $8.34, placing the stock +13.0% above today's low and -0.9% off the high.

Cartesian Therapeutics(RNAC) shares are trading with a volume of 278.12K, against a daily average of 184.3K.

During the past year, Cartesian Therapeutics(RNAC) stock moved between $5.60 at its lowest and $15.57 at its peak.

During the past year, Cartesian Therapeutics(RNAC) stock moved between $5.60 at its lowest and $15.57 at its peak.

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own RNAC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.